SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-003765
Filing Date
2023-01-19
Accepted
2023-01-19 16:01:33
Documents
16
Period of Report
2023-01-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea171886-8k_allarity.htm   iXBRL 8-K 41682
2 EMPLOYMENT AGREEMENT WITH JAMES G. CULLEM DATED JANUARY 12, 2023 ea171886ex10-1_allarity.htm EX-10.1 159120
3 EMPLOYMENT AGREEMENT WITH JOAN BROWN DATED JANUARY 12, 2023 ea171886ex10-2_allarity.htm EX-10.2 157241
4 GRAPHIC ex10-1_001.jpg GRAPHIC 4116
5 GRAPHIC ex10-2_001.jpg GRAPHIC 14105
  Complete submission text file 0001213900-23-003765.txt   641448

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE allr-20230112.xsd EX-101.SCH 3227
7 XBRL LABEL FILE allr-20230112_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE allr-20230112_pre.xml EX-101.PRE 22359
10 EXTRACTED XBRL INSTANCE DOCUMENT ea171886-8k_allarity_htm.xml XML 3714
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41160 | Film No.: 23537434
SIC: 2834 Pharmaceutical Preparations